Lymphoma Clinical Trials in San Francisco

Showing 381-383 of 383 trials

Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients

NCT00057447

Evaluate the safety and efficacy of the dosing schedule of subcutaneous interferon gamma-1b (IFN g-1b) administered 3 times per week with Rituximab for 4 weeks, in patients with progressive or relapsed low-grade Non-Hodgkin's Lymphoma (NHL) International study with sites in the Czech Republic and Poland

Non-Hodgkin's Lymphoma

InterMune24 participantsStarted Mar 2003

Brisbane, California, United States

COMPLETEDPhase 228 miles

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

NCT00045864

The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with intermediate-and high- grade Non-Hodgkin's lymphoma.

Lymphoma, Non-Hodgkin

Chiron Corporation

Tucson, Arizona, United States • Newport Beach, California, United States • Sacramento, California, United States +30 more locations

Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

Lymphoma Trials in Other Cities

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Other Conditions in San Francisco